Tokio Marine Asset Management Co. Ltd. lowered its stake in CVS Health Corporation (NYSE:CVS) by 31.2% in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 10,339 shares of the pharmacy operator’s stock after selling 4,693 shares during the quarter. Tokio Marine Asset Management Co. Ltd.’s holdings in CVS Health Corporation were worth $832,000 as of its most recent filing with the SEC.

Several other hedge funds also recently bought and sold shares of the company. Keel Point LLC lifted its holdings in CVS Health Corporation by 0.7% in the 1st quarter. Keel Point LLC now owns 3,296 shares of the pharmacy operator’s stock worth $259,000 after buying an additional 22 shares in the last quarter. First City Capital Management Inc. grew its stake in shares of CVS Health Corporation by 0.3% during the first quarter. First City Capital Management Inc. now owns 12,771 shares of the pharmacy operator’s stock valued at $1,003,000 after acquiring an additional 40 shares in the last quarter. Elefante Mark B grew its stake in shares of CVS Health Corporation by 0.7% during the second quarter. Elefante Mark B now owns 6,400 shares of the pharmacy operator’s stock valued at $515,000 after acquiring an additional 45 shares in the last quarter. Norway Savings Bank grew its stake in shares of CVS Health Corporation by 0.3% during the second quarter. Norway Savings Bank now owns 17,014 shares of the pharmacy operator’s stock valued at $1,368,000 after acquiring an additional 50 shares in the last quarter. Finally, Sheets Smith Wealth Management grew its stake in shares of CVS Health Corporation by 0.6% during the second quarter. Sheets Smith Wealth Management now owns 9,171 shares of the pharmacy operator’s stock valued at $738,000 after acquiring an additional 55 shares in the last quarter. Institutional investors and hedge funds own 81.49% of the company’s stock.

In other news, Director Richard J. Swift sold 2,500 shares of the company’s stock in a transaction that occurred on Wednesday, August 16th. The stock was sold at an average price of $79.62, for a total value of $199,050.00. Following the sale, the director now directly owns 3,258 shares in the company, valued at approximately $259,401.96. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, COO Jonathan C. Roberts sold 85,743 shares of the stock in a transaction that occurred on Monday, September 18th. The stock was sold at an average price of $83.14, for a total value of $7,128,673.02. Following the completion of the transaction, the chief operating officer now directly owns 119,555 shares of the company’s stock, valued at $9,939,802.70. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 696,078 shares of company stock valued at $56,650,631. Corporate insiders own 0.61% of the company’s stock.

CVS Health Corporation (NYSE CVS) opened at 80.77 on Tuesday. The firm has a market cap of $82.11 billion, a price-to-earnings ratio of 16.09 and a beta of 0.92. The company’s 50-day moving average price is $79.57 and its 200-day moving average price is $79.01. CVS Health Corporation has a 52-week low of $69.30 and a 52-week high of $88.92.

CVS Health Corporation (NYSE:CVS) last posted its earnings results on Tuesday, August 8th. The pharmacy operator reported $1.33 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.31 by $0.02. The business had revenue of $45.69 billion for the quarter, compared to analysts’ expectations of $45.36 billion. CVS Health Corporation had a net margin of 2.93% and a return on equity of 17.47%. The firm’s revenue for the quarter was up 4.5% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.32 earnings per share. Analysts predict that CVS Health Corporation will post $5.88 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 3rd. Shareholders of record on Tuesday, October 24th will be paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.48%. The ex-dividend date is Monday, October 23rd. CVS Health Corporation’s dividend payout ratio is 39.92%.

CVS has been the topic of a number of analyst reports. Royal Bank Of Canada initiated coverage on CVS Health Corporation in a research report on Tuesday, September 19th. They set an “outperform” rating and a $95.00 target price on the stock. Jefferies Group LLC boosted their price target on CVS Health Corporation from $82.00 to $86.00 and gave the stock a “hold” rating in a research note on Friday, September 15th. Needham & Company LLC reissued a “hold” rating on shares of CVS Health Corporation in a report on Sunday, September 10th. BidaskClub downgraded CVS Health Corporation from a “hold” rating to a “sell” rating in a report on Friday, August 25th. Finally, Loop Capital assumed coverage on CVS Health Corporation in a research note on Thursday, August 24th. They set a “hold” rating and a $83.00 price objective for the company. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and fifteen have given a buy rating to the company’s stock. CVS Health Corporation has an average rating of “Buy” and a consensus price target of $90.58.

COPYRIGHT VIOLATION NOTICE: “Tokio Marine Asset Management Co. Ltd. Sells 4,693 Shares of CVS Health Corporation (CVS)” was published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this story on another website, it was illegally stolen and republished in violation of US & international copyright and trademark law. The correct version of this story can be read at https://www.thecerbatgem.com/2017/10/03/tokio-marine-asset-management-co-ltd-sells-4693-shares-of-cvs-health-corporation-cvs.html.

CVS Health Corporation Company Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health Corporation (NYSE:CVS)

Receive News & Stock Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related stocks with our FREE daily email newsletter.